Daniel C. Brookings

Characterization of the Interaction of Sclerostin with the Low Density Lipoprotein Receptor-related Protein (LRP) Family of Wnt Co-receptors

Gill Holdsworth, Patrick M. Slocombe, Carl Doyle et al. · Journal of Biological Chemistry · 2012 · 95 citations · Full text

Seletalisib: Characterization of a Novel, Potent, and Selective Inhibitor of PI3Kδ

Rodger A. Allen, Daniel C. Brookings, Mark Powell et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 44 citations

4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinase

Rikki Alexander, Ahrani Balasundaram, Mark Batchelor et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 42 citations · Full text

Pharmaceutical Chemistry, Medicine, Mechanism Of Action +6

An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis

Alexander Vugler, James P. O’Connell, Mai Ánh Nguyễn et al. · Frontiers in Pharmacology · 2022 · 34 citations · Full text

Asymmetric ethylmagnesiation of alkenes using a novel zirconium catalyst

Louise Bell, Daniel C. Brookings, Graham Dawson et al. · Tetrahedron · 1998 · 32 citations

Alkene Metathesis, Catalysis, Chemistry +2